Vectors having enhanced expression and methods of making and use

Details Vectors having enhanced expression and methods of making and use Vectors having enhanced expression and methods of making and use

1998-05-15

2000-10-10

Brusca, John S.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

4353201, 435 9141, 536 2372, C12P 2106

Patent

active

061300667

ABSTRACT:
Disclosed and claimed are vectors having enhanced expression and methods for making and using them. Enhancement of expression is from substantially co-temporal expression of at least one first nucleic acid molecule and at least one second nucleic acid molecule. The second nucleic acid molecule encodes a transcription factor or a translation factor or a transcription factor and a translation factor. The contemporaneous expression can be from operably linking the first and second nucleic molecules to a single promoter, or from operably linking the first nucleic acid molecule to a first promoter and the second nucleic molecule to a second promoter wherein the first and second promoters function substantially contemporaneously. Thus, the first and second nucleic acid molecules can be at the same locus in the vector, or at different loci. The second nucleic acid molecule can encode: one transcription factor or more than one transcription factor; or one translation factor or more than one translation factor; or at least one transcription factor and at least one translation factor. The transcription factor can be from vaccinia H4L, D6, A7, G8R, A1L, A2L, H5R, or combinations thereof. The translation factor can be from a K3L open reading frame, an E3L open reading frame, a VAI RNA, an EBER RNA, a sigma 3 open reading frame, a TRBP open reading frame, or combinations thereof. The vector can be a poxvirus such as an attenuated poxvirus, e.g., NYVAC, or ALVAC.

REFERENCES:
patent: 4738922 (1988-04-01), Haseltine et al.
patent: 5302517 (1994-04-01), Rhode, III
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. www.nih.gov
ews/panelrep. html, 1995.
Park et al., Proc. Natl. Acad. Sci. USA 91:4713-4717 (1994).

Affiliated with

Also associated with

Rating

Vectors having enhanced expression and methods of making and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vectors having enhanced expression and methods of making and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors having enhanced expression and methods of making and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2255303